Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-20-000064
Filing Date
2020-01-03
Accepted
2020-01-03 16:12:43
Documents
5

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT mnprs3shelf.htm S-3 233432
2 OPINION ON LEGALITY exhibit5opinionforms-3.htm EX-5 13153
3 CONSENTS OF EXPERTS AND COUNSEL exhibit23-1.htm EX-23 4859
4 IMAGE exhibit5opinionforms-3000.jpg GRAPHIC 8826
5 IMAGE mnprs3shelf000.jpg GRAPHIC 9778
  Complete submission text file 0001654954-20-000064.txt   278323
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235791 | Film No.: 20505462
SIC: 2834 Pharmaceutical Preparations